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Abstract
Background: Removing and sequestering synaptically released glutamate from the extracellular
space is carried out by specific plasma membrane transporters that are primarily located in
astrocytes. Glial glutamate transporter function can be monitored by recording the currents that
are produced by co-transportation of Na+ ions with the uptake of glutamate. The goal of this study
was to characterize glutamate transporter function in astrocytes of the spinal cord dorsal horn in
real time by recording synaptically evoked glutamate transporter currents.
Results: Whole-cell patch clamp recordings were obtained from astrocytes in the spinal substantia
gelatinosa (SG) area in spinal slices of young adult rats. Glutamate transporter currents were
evoked in these cells by electrical stimulation at the spinal dorsal root entry zone in the presence
of bicuculline, strychnine, DNQX and D-AP5. Transporter currents were abolished when synaptic
transmission was blocked by TTX or Cd2+. Pharmacological studies identified two subtypes of
glutamate transporters in spinal astrocytes, GLAST and GLT-1. Glutamate transporter currents
were graded with stimulus intensity, reaching peak responses at 4 to 5 times activation threshold,
but were reduced following low-frequency (0.1 – 1 Hz) repetitive stimulation.
Conclusion: These results suggest that glutamate transporters of spinal astrocytes could be
activated by synaptic activation, and recording glutamate transporter currents may provide a means
of examining the real time physiological responses of glial cells in spinal sensory processing,
sensitization, hyperalgesia and chronic pain.
Background
Spinal glial cells are now recognized as important partici-
pants in mechanisms of sensory encoding and the plastic-
ity underlying the generation of spinal sensitization,
hyperalgesia and chronic pain. Nevertheless, studies
implicating glial cells in these processes have been con-
fined to anatomical and behavioral approaches. An
important facet of glial functions within the central nerv-
ous system (CNS) that may be fundamental to their con-
tribution to sensory encoding in the spinal cord is the
clearance of glutamate from the extracellular space via
specific plasma membrane glutamate transporters [1-5].
Five cell membrane glutamate transporter proteins have
been cloned, including EAAT1, EAAT2, EAAT3, EAAT4
and EAAT5 [5,6]. The rodent analogs of EAAT1 (GLAST)
and EAAT2 (GLT-1) are expressed primarily in glial cells in
the CNS [1,5]. Synaptic transmission in various brain
structures such as the hippocampus has been shown to be
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potently shaped and regulated by the functional status of
these transporters [3,7]. Glutamate transporters are also
involved in spinal nociceptive processing [8]. For exam-
ple, inhibition of glutamate transporters in the spinal cord
elevates spinal extracellular glutamate concentrations,
alters glutamatergic synaptic transmission among lamina
II neurons [9], and produces spontaneous nociceptive
behaviors [10]. Dorsal horn neurons develop hyper-
responsiveness to mechanical and thermal stimuli after
blockade of glutamate transporters [11]. Peripheral nerve
injury [12,13] or chemotherapy [14] induced down-regu-
lation of glutamate transporter protein expression and
attenuation of glutamate uptake activity in the spinal dor-
sal horn.
The hypothesis tested here is that real time physiological
responses of glial cells, specifically astrocytes, to sensory
inputs could be measured by analysis of glutamate trans-
porter currents. The synaptic activation of glutamate trans-
porter currents in glial cells has been demonstrated in
culture [15,16] and in brain slices [17,18]. So far these
currents have not been characterized in spinal glial cells.
Here we demonstrate that electrophysiologically charac-
terized spinal astrocytes express two types of glutamate
transporters, GLAST and GLT-1. The glutamate transporter
currents in spinal astrocytes evoked by single stimulation
from dorsal root entry zone share some similar properties
with hippocampal astrocytes but also have their unique
characteristics.
Results
Identification of spinal astrocytes
Whole-cell recordings were obtained from 45 glial cells in
the SG of spinal cord dorsal horn. Glial cells were first vis-
ually identified as small, rounded cells with a soma diam-
eter less than 10 mm (Fig. 1A). We further distinguished
glial cells from neurons by their electrophysiological
properties after obtaining the whole-cell recording config-
uration. Glial cells were characterized by absence of action
potentials to injection of depolarizing currents steps up to
1200 pA while in current clamp mode and by the demon-
stration of passive current responses to voltage steps while
in voltage clamp mode (Fig. 1D). In addition, recorded
cells had a characteristically low mean input resistance of
24.4 ± 2.4 MW (n = 45), negative resting membrane poten-
tial of -74.1 ± 0.5 mV (n = 45), and mean membrane
capacitance of 11.4 ± 1.0 pF (n = 45).
Previous studies have shown that the four different types
of glial cells in spinal cord gray matter including astro-
cytes, oligodendrocytes, oligodendrocyte precursors and
astrocyte precursors, display distinct membrane current
responses to voltage steps [19]. Spinal cord astrocytes
were differentiated from oligodendrocytes and precursor
cells by their passive, non-decaying inward and outward
currents in response to hyperpolarizing and depolarizing
voltage steps, respectively. Astrocytes typically showed
small rectifying currents with voltage steps below -80 mV.
In the present study, only cells showing electrophysiolog-
ical characteristics of spinal cord astrocytes were chosen,
otherwise recordings were discarded. Recorded cells were
marked with Lucifer Yellow contained in the pipette solu-
tion and the physiological criteria for cell selection were
validated post-recording by immunostaining for the
astrocyte-specific marker glial fibrillary acidic protein
(GFAP) (Fig. 1C).
Characteristics of synaptically evoked glutamate 
transporter currents in spinal astrocytes
Single electrical stimuli delivered at the dorsal root entry
zone evoked a large inward current in astrocytes held at a
membrane potential of -80 mV (n = 15, Fig. 2). This
inward current decayed slowly, often lasting over 10 sec-
onds. In the presence of Ba2+, the slowly decaying inward
current was blocked and a fast inward current unmasked
(n = 15, Fig. 2). The fast inward currents were character-
ized by rapid onset with a rising t of 3.3 ± 0.3 ms, rela-
tively slow decay t of 11.3 ± 0.6 ms and half decay time
of 13.9 ± 0.3 ms when evoked by maximal (5 × threshold)
stimuli (n = 15, Fig. 3A). Stimulus evoked inward currents
in astrocytes were strongly, but reversibly, inhibited by
addition of cadmium (CdCl2, 40 mM, n = 3) or tetrodo-
toxin (TTX, 1 mM, n = 4) to the bath to block presynaptic
calcium channels and voltage-sensitive sodium channels,
respectively (Fig. 4). Thus, glutamate transporter currents
elicited in response to dorsal root entry zone stimulation
is dependent on the synaptic release of glutamate. The
minimal intensity threshold stimulus to evoke glutamate
transporter currents ranged between 0.5 and 1.0 mA. The
mean amplitude of transporter currents at threshold stim-
ulation was 18.4 ± 1.7 pA (n = 14). Increases in stimulus
intensity resulted in an increase in evoked glutamate
transporter current amplitude to a maximal mean
response of 77.7 ± 7.4 pA (n = 14) evoked at 4 to 5 times
threshold strength (Fig. 3A, B). The time course of gluta-
mate transporter currents evoked by varying stimulus
strength was assessed by scaling each of the responses to
the amplitude of the maximal response. The overlay of
these scaled currents shown in Fig. 3C indicates that the
stronger stimuli did not change the time course of evoked
glutamate transporter currents.
Pharmacological characterization of glial glutamate 
transport currents evoked by dorsal root entry zone 
stimulation
The fast inward current remained following addition of
DNQX [6,7-Dinitroquinoxaline-2, 3-dione (10 mM)], AP-
5 [D-2-Amino-5-phosphonopentanoic acid (25 mM)],
bicuculline methiodide (10 mM)] and strychnine hydro-
chloride (5 mM)] to the bath and thus was not mediatedMolecular Pain 2009, 5:36 http://www.molecularpain.com/content/5/1/36
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by AMPA, NMDA, gamma-amino-butyric acid-A (GABAA)
or glycine receptors (n = 15, Fig. 2). These currents were
also insensitive to the GABA transporter inhibitor SKF-
89976A (25 mM, n = 3) and nipecotic acid (100 mM, n =
3), and glycine transporter inhibitor sarcosine (500 mM, n
= 3). In contrast, this current was inhibited by glutamate
transporter antagonists. Application of dihydrokainate
(DHK, 300 mM), a nontransported inhibitor selective for
the glial GLT-1 transporter (IC50 = 23 mM for GLT-1 vs. = 3
mM for GLAST & EAAC1) [20], inhibited the evoked
response by 45.6% ± 6.4% (n = 6; Fig. 5A, B). While DL-
threo-b-benzyloxyaspartate (TBOA, 100 mM), a nonselec-
tive glial transporter inhibitor (IC50= 19 mM for EAAC1
[21], 68 mM for GLAST, and 6 mM for GLT-1, [22]), inhib-
ited the current by 82.7% ± 2.1% (n = 15; Fig. 5A, B). After
application of DHK, the decay of the remaining current
was slowed (11.6 ± 1.4 vs. 17.9 ± 2.6 ms before and after
DHK, n = 6, P < 0.01, Student's paired t-test), visibly when
the response with DHK was scaled to the peak of the con-
trol response (Fig. 5C). The prolongation of the response
in the presence of DHK suggests that synaptically released
glutamate remains elevated in the extracellular space
longer when uptake into astrocytes is reduced [17]. Block-
ade of glutamate transporter currents with TBOA revealed
Identification of astrocytes in spinal dorsal horn Figure 1
Identification of astrocytes in spinal dorsal horn. An astrocyte (arrow) with attached patch pipette (P) is shown when 
viewed in DIC (A) and under epifluorescence when filled with Lucifer Yellow (B). C, Anti-GFAP antibody labeling (red) super-
imposed on the cell loaded with Lucifer Yellow (green) shown in B. D, under voltage clamp, inward and outward currents 
(upper left) were evoked in the same cell, by depolarizing and hyperpolarizing voltage steps from a holding potential of -80 mV 
(lower left). I/V curve (upper right) shows the nearly linear current-voltage relationship with slight rectification during hyperpo-
larization from the recorded cell. Whole-cell membrane potential changes (lower right) induced by 200 ms steps of current (-
500 to 1200 pA) recorded from the same cell, noticing there is no action potential induced. Scale bar = 10 mm in A and B; 20 
mm in C.Molecular Pain 2009, 5:36 http://www.molecularpain.com/content/5/1/36
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a residual small slow-decaying inward current (Fig. 5A,
arrow) confirm the fast inward current (Fig. 2) as pro-
duced by glutamate transporter activity in dorsal horn
astrocytes [17,23,24].
Evoked glutamate transporter currents in astrocytes were 
gradually decreased in response to repetitive stimulation
Repetitive dorsal root entry zone stimulation was found
to result in reduced transporter currents. Stimuli adequate
to evoke maximal responses (2.5 – 5 mA, 0.2 ms) were
repeated at different interstimulus intervals (0.1, 0.3 and
1 Hz). As shown in Fig. 6, the evoked currents in astrocytes
were significantly decreased following the second stimu-
lus (71.2% ± 5.6% maximal current at 0.1 Hz, n = 5, P <
0.01, One-way ANOVA), then continued going down
slowly during stimulation at all frequencies tested (58.8%
± 3.1% maximal current following the last stimulus at 0.1
Hz, n = 5). As the frequency of the stimulation went
higher, the decrease in amplitudes of evoked glutamate
transporter currents became greater (71.2% ± 5.6% maxi-
mal current following the second stimulus at 0.1 Hz, n =
5 vs. 41.6% ± 4.4% at 1 Hz, n = 15, P < 0.01, One-way
ANOVA) and remained at the lower level (58.8% ± 3.1%
maximal current following the last stimulus at 0.1 Hz, n =
5 vs. 32.8% ± 2.7% at 1 Hz, n = 15, P < 0.01, One-way
ANOVA). When scaled to the peak of the maximal cur-
rent, the evoked current following each stimulus had the
same time course when compared to the maximal cur-
rents (Fig. 6C).
Discussion
The electrogenic properties of glutamate uptake through
glutamate transporters was used in this study to record
real time physiological responses of spinal dorsal horn
Spinal dorsal root entry zone stimulation evoked an inward current in spinal astrocytes Figure 2
Spinal dorsal root entry zone stimulation evoked an inward current in spinal astrocytes. In the presence of antag-
onists to GABAA and glycine receptors (bicuculline and strychnine), a slow-decaying inward current was recorded from a spinal 
astrocyte holding at -80 mV (n = 15, curve 1). Ba2+ (1 mM) largely blocked the slow-decaying inward current, but unmasked a 
fast-decaying inward current (curve 2, also visible with bigger scale in the lower box). A fast-decaying inward current was still 
largely preserved after the application of DNQX and D-AP5 to block AMPA and NMDA receptors, respectively (curve 3). All 
responses were from the same cell and represented averages of 5 trials.Molecular Pain 2009, 5:36 http://www.molecularpain.com/content/5/1/36
Page 5 of 11
(page number not for citation purposes)
astrocytes to sensory inputs [6,15,25]. The results show
that (1) stimulation of spinal cord dorsal root entry zone
elicits glutamate transporter currents in astrocytes located
in SG region, (2) spinal astrocytes express the glutamate
transporters GLT-1 and GLAST, and (3) the glutamate
transporter currents in spinal astrocytes share similar char-
acteristics with that in hippocampal astrocytes and cere-
bellar Bergmann glia.
Identification of spinal astrocytes
Astrocytes in spinal grey matter could be identified by
their electrophysiological characterization and immuno-
cytochemical staining for GFAP [19]. None of the
recorded cells showed any Na+ currents or action poten-
tials to intracellular current injection, which differentiated
them from neurons. These cells also had low input resist-
ance and very negative resting membrane potential, char-
Glutamate transporter currents recorded in spinal astrocytes reflect the intensity of synaptic activation Figure 3
Glutamate transporter currents recorded in spinal astrocytes reflect the intensity of synaptic activation. A-B, 
the amplitude of glutamate transporter currents recorded in a spinal astrocyte increases as the intensity of dorsal root entry 
zone stimulus increases (n = 14). The current reaches the maximal amplitude with 4 or 5 times threshold (T). C, normalization 
of responses in A to the same amplitude shows the same time course of each response.
Glutamate transporter current in spinal astrocytes is abolished by blockade of synaptic transmission Figure 4
Glutamate transporter current in spinal astrocytes is abolished by blockade of synaptic transmission. Bath appli-
cation of 40 mM CdCl2 (n = 3, A) or 1 mM TTX (n = 4, B) inhibited the evoked glutamate transporter current in spinal astro-
cyte, indicating the synaptic origin of these currents.Molecular Pain 2009, 5:36 http://www.molecularpain.com/content/5/1/36
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acteristic of glial cells. To identify astrocytes from other
types of glial cells, we first compared the pattern of mem-
brane current responses to voltage steps. Astrocytes dis-
played symmetrical outward and inward currents without
decay in response to a series of hyperpolarizing and depo-
larizing voltage steps [19]. The functional identification
criteria were validated with immunostaining to GFAP, a
well-known marker of astrocytes.
Glutamate transporter uptake currents in spinal astrocytes
It has been demonstrated that glutamate transporter pro-
teins are expressed abundantly in hippocampal astrocytes
and Bergmann glial cells by physiological and molecular
studies [16-18,26-30]. Spinal astrocytes in this study
showed slowly decaying inward currents in response to
dorsal root entry zone stimulation similar to that
observed in hippocampal astrocytes in response to affer-
ent stimulation of Shaffer collaterals [17,23,24,31]. The
long-lasting inward currents in forebrain neurons were
presumably due to potassium redistribution in the extra-
cellular space and could be blocked by an ionotropic
glutamate receptor antagonist, kynurenate [17,23,24,31].
Astrocytes potentially sense extracellular potassium con-
centration through inwardly rectifying potassium chan-
nels in their cellular membrane [32,33]. The majority of
the long-lasting inward current in spinal astrocytes was
confirmed as mediated by influx of potassium ions as it
was blocked by Ba2+ applied in the extracellular bath and
resulted in an unmasking of a transient, fast inward cur-
rent. Persistence of the residual rapid onset and fast-
decaying inward current in the presence of antagonists to
ionotropic glutamate, GABAA and glycine receptors and
the sensitivity of this current to glutamate transporter
blockers (TBOA and DHK) identifies this current as medi-
ated by electrogenic uptake of glutamate [17,26,31]. This
current could potentially be mediated by glutamate
metabotropic receptors, which were not tested in this set
of experiments. Yet, this possibility seems remote as the
Pharmacological characterization of glutamate transporter currents in spinal astrocytes evoked through dorsal root entry zone  stimulation Figure 5
Pharmacological characterization of glutamate transporter currents in spinal astrocytes evoked through dor-
sal root entry zone stimulation. A-B, bath application of DHK (300 mM), a selective antagonist for glial GLT-1 glutamate 
transporter, partially blocked the evoked glutamate transporter current (n = 6), while TBOA, a non-selective antagonist for 
glial glutamate transporter, almost completely blocked the evoked glutamate transporter current (n = 15). Notice that a slow-
decaying inward current (arrow) was not blocked by TBOA. *P < 0.01, DHK or TBOA vs. Control, Student's paired t-test. C, 
DHK slowed the decay of the glutamate transporter current, which was shown when the response in DHK was scaled to the 
peak of the control response (n = 6).Molecular Pain 2009, 5:36 http://www.molecularpain.com/content/5/1/36
Page 7 of 11
(page number not for citation purposes)
comparable fast inward current in hippocampal astrocytes
was not affected by metabotropic receptor antagonists in
other studies [17,18].
The majority of synapses in the CNS are ensheathed by
glial processes [34], giving a structural basis of glia-neuro-
nal communication. In the present study, the elimination
of glial glutamate transporter currents in response to affer-
ent stimulation by the blockade of presynaptic release of
glutamate with TTX or Cd2+ indicated that these currents
were evoked by synaptic activation. The glutamate trans-
porter current in spinal astrocytes in response to afferent
stimulation had similar dynamic properties to those
observed in glial cells of hippocampus and cerebellum
[17,18,26,31]. The rapid onset of evoked spinal glial cur-
rents with little delay after stimulation suggests that gluta-
mate diffuses out of the synaptic cleft rapidly in spinal
dorsal horn as well, reaching glutamate transporters
within a millisecond following release. Insufficient func-
tion of glutamate transporters in spinal astrocytes would
therefore be expected to result in glutamate "spillover" to
extrasynaptic spaces and activate high affinity receptors
such as NMDA and metabotropic glutamate receptors at
extrasynaptic sites and/or on neighboring synapses. This
finding suggests the possibility of an entirely new mecha-
nism of enhanced synaptic transmission in spinal cord
during hyperalgesia and chronic pain. The partial inhibi-
tion of the response by DHK and almost complete inhibi-
tion by TBOA indicated the co-existence of two subtypes
of glutamate transporters in spinal dorsal horn astroctyes:
GLT-1 and GLAST. It is consistent with the GLT-1 and
GLAST mRNA/immunohistochemical staining in rodent
spinal cord at this age [12,35,36].
Functional implication of glutamate transporters in spinal 
astrocytes
Although both neurons and glial cells express glutamate
transporters and participate in clearing extracellular gluta-
mate, several lines of evidence suggest that the vast major-
ity of synaptically released glutamate is transported into
glia [35,37-39]. The high-affinity glutamate transporters
expressed in astrocytes are essential for taking up the
Glutamate transporter currents in spinal astrocytes evoked by dorsal root entry zone stimulation with different frequencies Figure 6
Glutamate transporter currents in spinal astrocytes evoked by dorsal root entry zone stimulation with differ-
ent frequencies. A, glial transporter currents gradually reduced during repetitive stimulation at 3 different frequencies. 
Transporter currents were reduced to a greater degree with higher frequency of stimulation. B, representative responses of 
glial transporter currents evoked by stimulation with different frequencies, the response to the first ("1") and twentieth ("20") 
stimuli are displayed. All responses were from the same cell and represented averages of 5 trials. C, comparison of time 
courses between responses to the 1st and 20th stimuli shown in panel B, normalized to the same amplitude. Note that the 
response to the 20th stimulus showed similar kinetic characteristics when compared to the response to the 1st stimulus.Molecular Pain 2009, 5:36 http://www.molecularpain.com/content/5/1/36
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majority of glutamate released at excitatory synapses,
maintaining low extracellular glutamate and preventing
glutamate neurotoxicity [35,37-39]. Blocking glial gluta-
mate transporters results in both exaggerated amplitude
and longer duration excitatory postsynaptic currents
(EPSCs) [40-43], suggesting that glial glutamate trans-
porters play a critical role in limiting the extrasynaptic dif-
fusion of glutamate [44]. The loss of glial glutamate
transporter GLAST or GLT-1 produced elevated extracellu-
lar glutamate levels, neurodegeneration characteristic of
excitotoxicity, and a progressive paralysis [37]. Mice lack-
ing GLT-1 show lethal spontaneous seizures and increased
susceptibility to acute cortical injury due to increased level
of residual glutamate in the brain [38]. Although it
remains unknown how neuronal and glial glutamate
transporters function differently in spinal sensory process-
ing and chronic pain, the glial glutamate transporters cer-
tainly draw more attention since more than 80%
extracellular glutamate is uptaken by glial cells. There
have been several studies showing that glutamate trans-
porters may also play a similar role in spinal cord. Immu-
nohistochemical studies reveal that GLT-1 and GLAST are
abundantly expressed in astrocytes but not neurons or
microglia of spinal cord dorsal horn [14,35,36,45]. The
glutamatergic synaptic transmission in spinal lamina II
neurons was altered by pharmacologically blocking GLT-
1 [9]. Pharmacological inhibition of glutamate transport-
ers in the spinal cord elevates spinal extracellular gluta-
mate concentrations and produces spontaneous
nociceptive behaviors [10], and also resulted in the hyper-
sensitivity of spinal dorsal horn neurons to mechanical
and thermal stimuli [11]. Down-regulation of glutamate
transporter protein expression and attenuation of gluta-
mate uptake activity in the spinal dorsal horn is associated
with neuropathic pain induced by peripheral nerve injury
[12,13,45] or by chemotherapy [14]. Gene transfer of
GLT-1 in to spinal astrocyes attenuated the induction but
not maintenance of inflammatory and neuropathic pain
in rats [46].
However, not all studies have been in agreement on the
role of glial glutamte transporters in pain signaling. For
example, the induction of allodynia following intrathecal
injection of prostaglandin E2, prostaglandin F2, NMDA
or AMPA was diminished by spinal application of TBOA
[47]; and inhibition of GLT-1 activity or expression
reduced formalin-induced nociceptive behavior [48]. It
remains unclear whether these data indicate that gluta-
mate transporters show plasticity with the onset of patho-
logical pain or whether in these latter studies an excess of
glutamate resulted in activation of presynaptic metabo-
tropic receptors that in turn resulted in an anti-nociceptive
response profile.
It is well known that repetitive low-frequency noxious
stimuli applied to a spinal dorsal root result in a cumula-
tive depolarization and a progressive increase in action
potential output from dorsal horn neurons ("Windup")
[49-51]. The cellular mechanisms responsible for the gen-
eration of wind-up are complex and still incompletely
understood. Although the buildup of synaptically
released glutamate was thought to be involved in cumula-
tive depolarization of postsynaptic dorsal horn neurons
with repeated stimuli, there has not been an efficient way
to measure the concentration of glutamate in synaptic
cleft in spinal cord. Since the synapses are ensheathed by
glial processes [34], measurement of glial glutamate
uptake currents induced by activation of the transporters
has been suggested as an independent method of moni-
toring the presynaptic release of glutamate [17,26]. Sev-
eral studies have shown that synaptically evoked
glutamate transporter currents could be used to monitor
the presynaptic release of glutamate during long-term
potentiation [23,24,52]. The data shown here is consist-
ent with this thesis as glutamate transporter currents in
spinal astrocytes increase in amplitude and duration with
increasing strength of single afferent volleys delivered to
the dorsal root entry zone. The range of stimulus intensi-
ties delivered to the dorsal root entry zone, 0.5–5 mA in
amplitude and 0.2 ms in duration, were adequate to
encompass both low-threshold non-nociceptive as well as
higher threshold, potentially nociceptive fibers [53,54].
The constancy of time course of glutamate transporter cur-
rents across stimulus intensities indicate that spinal astro-
cytes use similar transporter capacity to manage glutamate
release from both sets of afferents and additionally that
there is normally a reserve capacity for both types of
inputs [39]. Thus, the gradual reduction in transporter
currents observed with repetitive stimulation at the dorsal
root entry zone across frequencies raises intriguing inter-
pretative possibilities. At least two explanations come to
mind. One, the reduced currents could reflect reduced
release of presynaptic glutamate or alternatively. Two, it
could reflect the saturation of the glial transporters during
repetitive stimulation. If saturated, it would have been
expected that later evoked transporter currents would
have a longer decay time resulting from the build-up of
higher concentrations of glutamate in the extrasynaptic
space, but this was not observed. Moreover, glutamate
transporters have very rapid turn-over rate in the continu-
ous presence of glutamate [17,39], and the total transport
capacity of glial transporters were not overwhelmed dur-
ing a brief high-frequency stimulation train at near-physi-
ological temperature, even when a majority of the
transporters are blocked by a competitive antagonist [55].
Thus, it seems unlikely that the glial transporters were sat-
urated during low-frequency repetitive dorsal root entry
zone stimulation in this study. Altenratively, it might be a
concern that the cotransport of 2 Na+ :1Glu- with counter-
transport of 1 K+ and 1 OH- involved in glutamate uptake
through glutamate transporter would result in transloca-
tion of 1 net positive charge and reduce the net electricMolecular Pain 2009, 5:36 http://www.molecularpain.com/content/5/1/36
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gradient. But the activation of a Cl- conductance concom-
itant with transport would provide a potential mechanism
to offset the depolarizing action of transmitter reuptake
and dampen cell excitability [56]. Hence, the decrease of
glial glutamate transporter currents recorded here during
repetitive stimulation is concluded to reflect reduced
release of presynaptic (afferent-derived) glutamate, which
argues against the build-up of glutamate in the synaptic
cleft in the formation of "windup" following repetitive
stimulation. Further studies need to be done to clarify this
issue.
Conclusion
The present study showed that spinal dorsal horn astro-
cytes possess functional glutamate transporters GLT-1 and
GLAST. These glutamate transporters in spinal astrocytes
could be activated by synaptic transmission in spinal dor-
sal horn. The glutamate transporter currents in spinal
astrocytes share some similar characteristics with that in
hippocampal astrocytes and cerebellar Bergmann glia.
Methods
Animals
All experiments were approved by the Institutional Ani-
mal Care and Use Committee at the University of Texas M.
D. Anderson Cancer Center and were performed in
accordance with the National Institutes of Health Guide-
lines for Use and Care of Laboratory Animals. Male
Sprague-Dawley rats (4–6 weeks; Charles River Laborato-
ries, Wilmington, MA) were used for this study and were
housed under a 12 h light/dark cycle with free access to
water and food. Every effort was made to limit the num-
bers, pain and discomfort of animals used.
Spinal cord slice preparation
Spinal cord slices were prepared as described previously
[9,53]. Briefly, 4- to 6-week-old rats were deeply anaesthe-
tized with isoflurane inhalation (3%). Previous studies
have shown this age rat fully capable of mature nocicep-
tive signaling and development of hyperalgesia [57]. After
a laminectomy was performed, the lumber spinal cord
was quickly removed and placed into ice-cold oxygenated
(95%O2 + 5% CO2) solution consisting of (mM): Sucrose,
117; KCl, 3.6; NaH2PO4, 1.2; MgCl2, 1.2; CaCl2, 2.5;
NaHCO3, 25; Glucose, 12. The pia-arachnoid membrane
was carefully peeled off and a block of the spinal cord
from L3 to S1 was embedded in 4% agar. Transverse slices
(400 mm thick) from lumber segments L4 to L6 were cut
on a vibratome (series 1000, Technical Products Interna-
tional Inc., St. Louis. MO). The slices were then transferred
to Kreb's solution (composition in mM: NaCl, 117; KCl,
3.6; NaH2PO4, 1.2; MgCl2, 1.2; CaCl2, 2.5; glucose, 11;
NaHCO3, 25) bubbled with 95%O2 and 5% CO2 at 37°C,
and allowed to equilibrate at least for 1 h before record-
ing. The rats were euthanized by overdose of isoflurane
(%5) inhalation after the spinal cord was removed.
Electrophysiology
Whole-cell patch clamp recordings from glial cells in
superficial spinal cord were obtained as previously
described [19]. An individual slice was transferred to a
recording chamber and continually perfused with oxygen-
ated Kreb's solution (3 ml/min) at 37°C. Cells in the sub-
stantia gelatinosa (SG) region of spinal dorsal horn
(lamina II) were visualized using a 60× water-immersion
objective on an upright microscope (Olympus, BX50WI,
Japan) equipped with infrared and differential interfer-
ence contrast (DIC) optics. Patch pipettes were made from
borosilicate glass (World Precision Instruments, Sarasota,
FL) with resistances of 4–8 MW when filled with pipette
solutions containing (in mM): 145 K-gluconate, 5 NaCl, 1
MgCl2, 0.2 EGTA, 10 HEPES, 2 Mg-ATP and 0.1 Na-GTP,
PH 7.2. Membrane currents were measured with the
patch-clamp technique on the whole-cell recording con-
figuration [58]. Whole-currents were amplified using a
Multiclamp 700B amplifier (Axon Instruments, Sunny-
vale, CA), filtered at 5 kHz and sampled at 10 kHz in dig-
ital forms using a Digidata 1322A digitizing board (Axon
Instruments, Sunnyvale, CA) interfaced with a computer
system. Access resistance was monitored continuously
throughout the experiments and was typically 10–20 MW.
The recording was abandoned when the access resistance
changed more than 20%. The input resistance (Rin) of the
cell was calculated based on the steady state current
change during application of a 10 mV depolarizing and/
or 10 mV hyperpolarizing pulse. The membrane capaci-
tance (Cm) of the cell was calculated from the transient
capacitive currents during the application of a 10 mV
depolarizing or hyperpolarizing pulse, using a single
spherical compartment model. The resting membrane
potential (Vm) was recorded in current clamp mode. For
all the experiments, glial cells were recorded at a holding
potential of -80 mV unless otherwise noted. Single stimuli
of intensity 0.5–5 mA; 0.2 ms, was applied through a con-
centric bipolar stainless steel electrode placed in the dor-
sal root entry zone [9,53,54]. Evoked responses were
elicited with a constant-current stimulator (Master 8,
A.M.P. Instruments Ltd, Israel). Leak subtraction and
compensations of capacitance and series resistance were
not applied. To label cells for later morphological identi-
fication and antigenic identification, 0.1% Lucifer Yellow
(dilithium salt) was added into the pipette solution. The
morphological characteristics were examined with fluo-
rescence illumination after recording. The images were
captured with a digital camera and stored in digital form
for later analysis.
Immunocytochemistry
After recordings, slices were transferred to a fixation
medium containing 4% paraformaldehyde in phosphate
buffer (PB) and stored at 4°C. The next day, slices were
washed three times with phosphate-buffered saline (PBS)
for 1 h and were incubated for 15 min with 1% Triton X-Molecular Pain 2009, 5:36 http://www.molecularpain.com/content/5/1/36
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100, 5% normal donkey serum (NDS, Chemicon) in PBS.
After that slices were incubated for 1 h in the blocking
solution containing 0.2% triton, 5% NDS in PBS. Slices
were then incubated with Cy3-conjugated antibody
against GFAP (Sigma, dilution on 1:500) for 2 h at room
temperature in the blocking solution. Slices were then
washed in PBS and mounted on glass coverslips and were
viewed on a Nikon microscope (Nikon, Eclipse E600,
Japan) with a X-cite 120 fluorescence illumination system
(EXFO, Canada).
Chemcials
6,7-Dinitroquinoxaline-2, 3-dione (DNQX), D-2-Amino-
5-phosphonopentanoic acid (D-AP5), DL-threo-b-benzy-
loxyaspartate (TBOA), SKF-89976A, nipecotic acid, sarco-
sine and dihydrokainate (DHK) were obtained from
Tocris (Missouri, USA). All other chemicals were obtained
from Sigma-Aldrich (St. Louis, MO, USA) unless other-
wise noted.
Statistics
All results are presented as means ± S.E.M. The error bars
in all figures indicate S.E.M. Differences between means
were tested for significance using Student's paired t-test or
One-way ANOVA followed by post hoc, pair-wise compa-
sions (Student-Newman-Keuls method) with an alpha
value of P < 0.05.
Abbreviations
SG: substantia gelatinosa; DNQX: 6,7-Dinitroquinoxa-
line-2, 3-dione; D-AP5: D-2-Amino-5-phosphonopenta-
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aminoethyl)-N, N, N', N'-tetraacetic acid; PB: phosphate
buffer; NDS: normal donkey serum.
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